Hemo Organic Limited Submits Quarterly Compliance Certificate for Q4FY26
Hemo Organic Limited submitted its quarterly compliance certificate under SEBI Regulation 74(5) for Q4FY26, confirming proper dematerialization processes. MCS Share Transfer Agent Limited issued the certificate on 8th April, 2026, validating that all securities were properly processed, certificates were mutilated after verification, and depository names were updated in member registers within 15 days. The submission demonstrates the company's adherence to regulatory requirements for the quarter ended 31st March, 2026.

*this image is generated using AI for illustrative purposes only.
Hemo organic Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2026.
Regulatory Compliance Submission
The company submitted the compliance certificate on 9th April, 2026, in accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate was issued by MCS Share Transfer Agent Limited, the company's registrar and share transfer agent, dated 8th April, 2026.
| Parameter: | Details |
|---|---|
| Quarter Period: | 31st March, 2026 |
| Certificate Date: | 8th April, 2026 |
| Submission Date: | 9th April, 2026 |
| Registrar: | MCS Share Transfer Agent Limited |
Certificate Confirmation Details
MCS Share Transfer Agent Limited confirmed several key compliance aspects in their certificate. The registrar verified that all securities received from depository participants for dematerialization during the quarter were properly confirmed to the depositories. Additionally, they ensured that securities comprised in the certificates have been listed on stock exchanges where the company's earlier issued securities are already listed.
The certificate also confirms that security certificates received for dematerialisation were mutilated and cancelled after due verification by the depository participant. Importantly, the names of the depositories were substituted in the register of members as registered owners within the mandatory 15-day period.
Company and Registrar Information
Hemo Organic Limited, incorporated under CIN L24231GJ1992PLC018224, is headquartered in Ahmedabad, Gujarat. The company's managing director, Vishwambar Kameshwar Singh (DIN: 09822587), signed the submission letter digitally on 9th April, 2026.
MCS Share Transfer Agent Limited, operating under CIN U67120WD2011PLC165872, serves as the company's registrar and share transfer agent. The Ahmedabad-based registrar is located at Shatdal Complex on Ashram Road and was represented by their authorized signatory in issuing the compliance certificate.
Regulatory Significance
This quarterly submission represents standard regulatory compliance for listed companies, ensuring transparency in dematerialization processes and maintaining accurate shareholder records. The certificate validates that the company and its registrar have adhered to SEBI's prescribed timelines and procedures for handling securities dematerialization during the quarter ended 31st March, 2026.
Historical Stock Returns for Hemo Organic
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.97% | +2.74% | -9.29% | +38.17% | +16.20% | -19.14% |
Will Hemo Organic Limited's consistent regulatory compliance improve its ESG ratings and attract institutional investors?
How might SEBI's evolving digitalization initiatives impact the dematerialization process requirements for companies like Hemo Organic in upcoming quarters?
Could MCS Share Transfer Agent Limited's efficient compliance handling lead to expanded client relationships with other listed companies?




























